论文部分内容阅读
目的:探讨并研究稳心颗粒治疗老年慢性性心律失常的临床疗效及生活质量的影响。方法:以医院自2014年8月—2015年10月收治的老年慢性心律失常患者90例,采用随机数字表法将其分为两组,每组各30例。其中对照组采用常规药物复方丹参进行治疗,研究组采用复方丹参+稳心颗粒进行治疗。对两组患者采用不同的方式进行治疗后,比较两组患者的PR间期、心率以及治疗状况。结果:研究组患者总有效为91.1%,对照组总有效为64.4%,两组差距较明显,具有统计学意义(P<0.05)。研究组患者治疗后的PR间期及心率的变化均明显优于对照组,两组差距较明显,具有统计学意义(P<0.05)。研究组患者术后出现心悸、心绞痛、低血压的不良反应明显低于对照组两组差距较明显,具有统计学差异(P<0.05)。结论:对老年慢性心律失常患者采用稳心颗粒治疗的患者,能够有效的改善患者的临床症状,且能够有效的减少患者的心肌功能,整体预后效果较好,无明显并发症状况。患者以及患者家属较为满意,值得在临床上推广。
Objective: To investigate and study the effect of Wenxinkeli on clinical efficacy and quality of life in senile patients with chronic cardiac arrhythmia. Methods: Ninety elderly patients with chronic arrhythmia admitted from August 2014 to October 2015 in our hospital were divided into two groups (n = 30 in each group) by random number table. Among them, the control group was treated with routine drug compound Salvia miltiorrhiza, while the study group was treated with compound Salvia miltiorrhiza and Wenxin granule. After two groups of patients were treated differently, PR interval, heart rate and treatment status were compared between the two groups. Results: The total effective rate was 91.1% in the study group and 64.4% in the control group, with a significant difference between the two groups (P <0.05). The changes of PR interval and heart rate in study group were significantly better than those in control group. The difference between the two groups was statistically significant (P <0.05). Adverse reactions of heart palpitations, angina pectoris and hypotension after operation in study group were significantly lower than those in control group, with significant difference (P <0.05). Conclusion: The treatment of elderly patients with chronic arrhythmia Wenxin particles can effectively improve the patient’s clinical symptoms, and can effectively reduce the patient’s myocardial function, the overall prognosis is better, no significant complications. Patients and their families are more satisfied, it is worth in the clinical promotion.